<html>
<head>
   
   <title>2015 Gynecologic Oncology Conference in Barcelona</title>
</head>
<body bgcolor="#fff" style="margin: 0; padding: 0; background-color: #fff; background-position: top center; background-repeat: no-repeat repeat-y;">

<table width="100%" cellspacing="10" cellpadding="0">
   <tr>
      <td align="center" valign="top">
      
      <table class="main" cellspacing="0" border="0" bgcolor="#ffffff" style="border: 3px solid #666; padding: 10px; background-repeat: no-repeat; background-color: #ffffff;" cellpadding="0" width="580">
        

            <tr>
              <td height="94" align="left" valign="bottom"><a href="http://www.primeoncology.org/live_education/solid_tumor/gyncongress2015.aspx"><img src="http://development.primeoncology.org/live_education/solid_tumor/~/media/Images/Activity/2015/gyn_con/GYN-CONGRESS-2015_Banner-v2_997x157.ashx?w=936" width="600" height="94"></a></td>
            </tr>
            <tr><td align="center"><p style="color: #f00"><strong>Register Now: Early Registration Deadline 1 November 2014</strong></p></td></tr>
            <tr>
              <td align="center" valign="bottom"><table width="480" height="50" cellpadding="0" cellspacing="0">
              </table>
              </td>
            </tr>
            <tr>
              <td class="agenda" align="left" valign="bottom" style="margin: 0; padding: 0;"><table class="agenda" cellspacing="0" border="0" style="font-family: Arial; font-size: 12px; font-weight: normal; color: #4c4c4c;" cellpadding="0" width="580">
              </table></td>
            </tr>
            <tr>
              <td align="center">
              <table width="595" cellspacing="0" cellpadding="0">
                <tr align="left" rowspan="3" valign="top">
                  <td width="372" valign="top" class="mainbar" align="left"><table>
                    <tr>
                      <td><div style="border-bottom: #FF7E3E solid 1px;">
                        <h2 style="padding: 0; margin: 0; font-family: Arial, Helvetica, sans-serif; font-size: 14px; font-weight: bold; color: #F68025"><br>
                          Meeting Overview</h2>
                      </div></td>
                    </tr>
                    <tr>
                      <td><p style="padding: 0; margin: 4px 0 0 0; font-family: Arial; font-size: 12px; font-weight: normal; color: #4c4c4c;">We are pleased to invite you to the <em>2015 Progress and Controversies in Gynecologic Oncology Conference</em>, to be held in Barcelona, Spain, on 16-17 January 2015.<br><br>

This meeting will serve as a valuable forum for the presentation and discussion of newly available data across various gynecologic malignancies including ovarian, cervical, and endometrial cancers. Participants will be provided with updates on practice-changing data in a practical and interactive format, fostering discussion, and impacting clinical outcomes for patients.

</p>
                        <br>
                        <a href="http://www.primeoncology.org/live_education/solid_tumor/gyncongress2015.aspx" style="text-decoration: none;"><img src="http://primehc.org/email/ascoBC/register.gif" border="0" alt="Register Now" style="border: none;" /></a>
                        <br>
                        <p style="padding: 0; margin: 4px 0 0 0; font-family: Arial; font-size: 12px; font-weight: normal; color: #4c4c4c;">Please go to our Website for full registration fee information.</p>
                      </td>
                    </tr>
                  </table>
                    <table cellspacing="0" cellpadding="4" width="100%">
                      <tr>
                        <td><div style="border-bottom: #FF7E3E solid 1px;">
                          <h2 style="padding: 0; margin: 0; font-family: Arial, Helvetica, sans-serif; font-size: 14px; font-weight: bold; color: #F68025;"><br>
Agenda</h2>
                        </div></td>
                      </tr>
                      <tr>
                      <td valign="top">
                    <table class="agenda" border="0" style="font-family: Arial; font-size: 12px; font-weight: normal; color: #4c4c4c;" cellpadding="0" cellspacing="5" width="100%">
  <tbody>
    <tr><td colspan="2" style="padding-bottom: 12px"><strong>Friday, 16 January 2015</strong></td></tr>
        <tr>
            <td valign="top">13.00</td>
            <td style="padding-bottom: 12px">
            <p>Welcome and introduction<br /></p>
            </td>
       <tr>
            <td valign="top"><strong>Session I</strong></td>
            <td style="padding-bottom: 12px">
            <p><strong>Cervical Cancer and Vulvar Cancer</strong></p>
            </td>
        </tr>
        <tr>
            <td valign="top" width="82">13.10</td>
            <td style="padding-bottom: 12px">
            <p>Current status of treatment for vulvar cancer<br />
            <em>Sven Mahner, MD, PhD</em></p>
            </td>
        </tr>
        <tr>
            <td valign="top">13.40</td>
            <td style="padding-bottom: 12px">
            <p>Technical innovations in robotic surgery<br />
            <em>Jan Persson, MD, PhD</em></p>
            </td>
        </tr>
        <tr>
            <td valign="top">14.10</td>
            <td style="padding-bottom: 12px">
            <p>Update on neoadjuvant chemotherapy in cervical cancer <br />
            <em>Nicoletta Colombo, MD</em></p>
            </td>
        </tr>
        <tr>
            <td valign="top">14.40</td>
            <td style="padding-bottom: 12px">
            <p>Update on targeted therapy and immunotherapy for cervical cancer<br />
            <em>Bradley J. Monk, MD, FACS, FACOG</em></p>
            </td>
        </tr>
        <tr>
            <td valign="top">15.10</td>
            <td style="padding-bottom: 12px">
            <p>Break</p>
            </td>
        </tr>
         <tr>
            <td valign="top"><strong>Session II</strong></td>
            <td style="padding-bottom: 12px">
            <p><strong>Endometrial Cancer and Beyond</strong></p>
            </td>
        </tr>
        <tr>
            <td valign="top" width="75">15.40</td>
            <td style="padding-bottom: 12px">
                <p>Debate <br>Role of radiotherapy in grade 3 FIGO IB endometrial cancer<br>  
                <em>Pro Radiotherapy: Speaker TBD <br>Contra Radiotherapy: Mansoor Mirza, MD</em></p>
            </td>
        </tr>
        <tr>
            <td valign="top">16.30</td>
            <td style="padding-bottom: 12px">
            <p>Treatment of recurrent endometrial cancer and evaluation of new agents<br />
            <em>Andr&eacute;s Poveda, MD</em></p>
            </td>
        </tr>
        <tr>
            <td valign="top">17.00</td>
            <td style="padding-bottom: 12px">
            <p>What are the oncologic risks of morcellation of the uterus?<br />
            <em>Fr&eacute;d&eacute;ric Amant, MD, PhD </em></p>
            </td>
        </tr>
        <tr>
            <td valign="top">17.30</td>
            <td style="padding-bottom: 12px">
            <p>Concluding remarks: Day 1</p>
            </td>
        </tr>
        <tr>
            <td valign="top">17.35</td>
            <td style="padding-bottom: 12px">
            <p>Adjourn</p>
            </td>
        </tr>
        <tr>
            <td valign="top" style="padding-bottom: 12px">18.15 <br>-19.30</td>
            <td style="padding-bottom: 12px">
            <p>Industry-supported satellite symposium</p>
            </td>
        </tr>
<!--         SECOND DAY -->
         <tr><td colspan="2" style="padding-bottom: 12px"><strong>Saturday, 17 January 2015</strong></td></tr>
        <tr>
            <td valign="top">8.30</td>
            <td style="padding-bottom: 12px">
            <p>Welcome and introduction<br /></p>
            </td>
        </tr>
       <tr>
            <td valign="top"><strong>Session III</strong></td>
            <td style="padding-bottom: 12px">
            <p><strong>Ovarian Neoplasm I: Emerging Concepts</strong></p>
            </td>
        </tr>
        <tr>
            <td valign="top" width="75">8.35</td>
            <td style="padding-bottom: 12px">
            <p>The impact of molecular testing on therapeutic decisions in ovarian cancer<br />
            <em>Michael Birrer, MD, PhD</em></p>
            </td>
        </tr>
        <tr>
            <td valign="top">9.05</td>
            <td style="padding-bottom: 12px">
            <p>Evolving role of upfront and postoperative imaging in ovarian cancer<br />
            <em>Vincent Vandecaveye, MD, PhD</em></p>
            </td>
        </tr>
        <tr>
            <td valign="top">9.35</td>
            <td style="padding-bottom: 12px">
            <p>Future of targeted agents and combinations in ovarian cancer<br />
            <em>Stanley B. Kaye, MD</em></p>
            </td>
        </tr>
        <tr>
            <td valign="top">10.05</td>
            <td style="padding-bottom: 12px">
            <p>Break</p>
            </td>
        </tr>
         <tr>
            <td valign="top"><strong>Session IV</strong></td>
            <td style="padding-bottom: 12px">
            <p><strong>Ovarian Neoplasm II: Practical Applications in the First-Line Setting</strong></p>
            </td>
        </tr>
        <tr>
            <td valign="top" width="75">10.40</td>
            <td style="padding-bottom: 12px">
                <p>Personalized medicine: Identification and treatment of fragile patients <br>  
                <em>Felix Hilpert, MD, DMSci</em></p>
            </td>
        </tr>
        <tr>
            <td valign="top">11.10</td>
            <td style="padding-bottom: 12px">
            <p>Debate: HIPEC plays a role in treatment of advanced ovarian cancer<br />
            <em>Pro: Anna Fagotti, MD, PhD <br>Contra: Phillip Harter, MD</em></p>
            </td>
        </tr>
        <tr>
            <td valign="top">11.50</td>
            <td style="padding-bottom: 12px">
            <p>Break</p>
            </td>
        </tr>
        <tr>
            <td valign="top" style="padding-bottom: 12px">12.15 <br>-13.30</td>
            <td style="padding-bottom: 12px">
            <p>Industry-supported satellite symposium</p>
            </td>
        </tr>
        <tr>
            <td valign="top"><strong>Session V</strong></td>
            <td style="padding-bottom: 12px">
            <p><strong>Borderline Ovarian Tumors</strong></p>
            </td>
        </tr>
        <tr>
            <td valign="top" width="75">13.45</td>
            <td style="padding-bottom: 12px">
                <p>Pathologist's view on the current status of borderline tumors<br>  
                <em>Jaime Prat, MD, PhD, FRCPath</em></p>
            </td>
        </tr>
        <tr>
            <td valign="top">14.15</td>
            <td style="padding-bottom: 12px">
            <p>Clinical aspects: Fertility-sparing surgery of borderline ovarian tumors<br />
            <em>Philippe Morice, MD</em></p>
            </td>
        </tr>
        <tr>
            <td valign="top">14.45</td>
            <td style="padding-bottom: 12px">
            <p>Break</p>
            </td>
        </tr>
         <tr>
            <td valign="top"><strong>Session VI</strong></td>
            <td style="padding-bottom: 12px">
            <p><strong>Ovarian Neoplasm III: Recurrence</strong></p>
            </td>
        </tr>
        <tr>
            <td valign="top" width="75">15.00</td>
            <td style="padding-bottom: 12px">
                <p>Interactive Clinical Case: <br>Platinum-resistant disease<br>  
                <em>Ignace Vergote, MD, PhD</em></p>
            </td>
        </tr>
        <tr>
            <td valign="top">15.30</td>
            <td style="padding-bottom: 12px">
            <p>Interactive Clinical Case: <br>Platinum-sensitive disease<br>
            <em>Andreas du Bois, MD, PhD</em></p>
            </td>
        </tr>
        <tr>
            <td valign="top">16.00</td>
            <td style="padding-bottom: 12px">
            <p>Ovarian cancer patients who have received multiple prior therapies: When to stop or continue treatment?<br />
            <em>Eric Pujade-Lauraine, MD, PhD</em></p>
            </td>
        </tr>
        <tr>
            <td valign="top">16.30</td>
            <td style="padding-bottom: 12px">
            <p>Concluding remarks: Day 2</p>
            </td>
        </tr>
        <tr>
            <td valign="top">16.45</td>
            <td style="padding-bottom: 12px">
            <p>Adjourn</p>
            </td>
        </tr>
    </tbody>
</table>           

                      </td>
                      </tr>
                    </table>
                          <table cellspacing="0" cellpadding="4" width="100%">
                      <tr>
                        <td><div style="border-bottom: #FF7E3E solid 1px;">
                          <h2 style="padding: 0; margin: 0; font-family: Arial, Helvetica, sans-serif; font-size: 14px; font-weight: bold; color: #F68025;"><br><br>

Target Audience</h2>
                        </div></td>
                      </tr>
                      <tr>
                      <td> <p style="padding: 0; margin: 0; font-family: Arial; font-size: 12px; font-weight: normal; color: #4c4c4c;">The <em>2015 Progress and Controversies in Gynecologic Oncology Conference</em> is intended for gynecologists, oncologists, radiation therapists, surgeons, pathologists, and other practitioners including allied health professionals involved in the diagnosis and management of gynecologic malignancies.
</p>
                      </td>
                      </tr>
                    </table>
                          <table cellspacing="0" cellpadding="4" width="100%">
                      <tr>
                        <td><div style="border-bottom: #FF7E3E solid 1px;">
                          <h2 style="padding: 0; margin: 0; font-family: Arial, Helvetica, sans-serif; font-size: 14px; font-weight: bold; color: #F68025;"><br>
Learning Objectives</h2>
                        </div></td>
                      </tr>
                      <tr>
                      <td valign="top"> <p style="padding: 0; margin: 0; font-family: Arial; font-size: 12px; font-weight: normal; color: #4c4c4c;">After successful completion of this educational activity, participants should be able to:</p>
<ul style="margin:5px 30px 0px 30px !important; padding:0px 10px 0px 30px !important; font-family: Arial; font-size: 12px; font-weight: normal; color: #4c4c4c;">
    <li style="margin-top: 0px; margin-bottom: 0px; ">Develop a practical approach to cervical cancer and vulvar cancer disease management</li>
    <li style="margin-top: 0px; margin-bottom: 0px; ">Discuss the role of radiotherapy and systemic therapies in the management of endometrial cancer</li>
    <li style="margin-top: 0px; margin-bottom: 0px; ">Derive the optimal management of ovarian cancer in the first-line setting based on disease stage and clinical presentation</li>
    <li style="margin-top: 0px; margin-bottom: 0px; ">Assess standard and emerging therapeutic options for recurrent ovarian cancer and discuss their impact on patient outcomes</li>

</li>
</ul>
                      </td>
                      </tr>
                    </table> <table cellspacing="0" cellpadding="4" width="100%">
                      <tr>
                        <td><div style="border-bottom: #FF7E3E solid 1px;">
                          <h2 style="padding: 0; margin: 0; font-family: Arial, Helvetica, sans-serif; font-size: 14px; font-weight: bold; color: #F68025;"><br>
Accommodations</h2>
                        </div></td>
                      </tr>
                      <tr>
                      <td valign="top"> <p style="padding: 0; margin: 0; font-family: Arial; font-size: 12px; font-weight: normal; color: #4c4c4c;">A limited number of rooms are available at the Crowne Plaza Barcelona - Fira Center (meeting venue).
Delegates are recommended to make their hotel reservations as early as possible.
You can book your hotel room with the online registration form at the registration
tab or at <a href="http://www.prIMEoncology.org/gyncongress2015">www.prIMEoncology.org/gyncongress2015</a> or send an email to <a href="mailto:registrations.gyn2015@prIMEoncology.org">registrations.gyn2015@prIMEoncology.org</a>. </p></td>
                      </tr>
                    </table>     
                      <table width="100%" cellspacing="0" cellpadding="4">
                      
                    </table>
                 </td>
                  <td width="5">                   </td>
                  <td width="216" valign="top" class="sidebar" align="left">
                  
                  
                  
                  <table width="100%" cellspacing="0" cellpadding="4">
                    <tr>
                      <td class="sideTitle"><div style="border-bottom: #FF7E3E solid 1px;">
                        <h3 style="padding: 0; margin: 0; font-family: Arial, Helvetica, sans-serif; font-size: 14px; font-weight: bold; color: #F68025;"><br>
                          Date &amp; Location</h3>
                      </div></td>
                    </tr>
                    <tr>
                      <td><p style="font-family: Arial; font-size: 12px; font-weight: normal; color: #4c4c4c;"><strong>16 &ndash; 17 January 2015</strong><br>
                        <br>
                Crowne Plaza Barcelona Fira Center<br>
Avda Rius I Taulet, 1-3<br>
Barcelona, Spain<br>
                      </p></td>
                    </tr>
                  </table>
                  <table width="100%" cellspacing="0" cellpadding="4">
                    
                    
                  </table>
                    <table width="100%" cellspacing="0" cellpadding="4">
                      <tr>
                        <td class="sideTitle"><div style="border-bottom: #FF7E3E solid 1px;">
                          <h3 style="padding: 0; margin: 0; font-family: Arial, Helvetica, sans-serif; font-size: 14px; font-weight: bold; color: #F68025;"><br>
Co-Chairs</h3>
                        </div>
                        </td></tr>
                        <tr>
                          <td valign="top"><p style="font-family: Arial; font-size: 12px; font-weight: normal; color: #4c4c4c;">
Andreas du Bois, MD, PhD<br>
Klinikum Essen Mitte<br>
Essen, Germany <br>
<br>
Stanley B. Kaye, MD<br>
The Royal Marsden Hospital<br>
Sutton, United Kingdom <br><br>

  Ignace Vergote, MD, PhD<br>
University Hospital Gasthuisberg<br>
Leuven, Belgium <br>

</p></td>
                        </tr>
                                              <tr>
                        <td class="sideTitle"><div style="border-bottom: #FF7E3E solid 1px;">
                          <h3 style="padding: 0; margin: 0; font-family: Arial, Helvetica, sans-serif; font-size: 14px; font-weight: bold; color: #F68025;"><br>
Scientific Committee</h3>
                        </div>
                        </td></tr>
                        <tr>
                          <td valign="top"><p style="font-family: Arial; font-size: 12px; font-weight: normal; color: #4c4c4c;">
                          Nicoletta Colombo, MD<br>
University of Milan-Bicocca<br>
Milan, Italy <br><br>

Bradley J. Monk, MD, FACS, FACOG<br>
Creighton University School of Medicine<br>
at St Joseph's Hospital and Medical Center<br>
Phoenix, Arizona, United States <br><br>

Andr&eacute;s Poveda, MD<br>
Fundaci&oacute;n Instituto Valenciano de Oncolog&iacute;a<br>
Valencia, Spain <br><br>

Eric Pujade-Lauraine, MD, PhD<br>
Centre Hospitalier Universitaire Hôtel-Dieu<br>
Paris, France
</p></td>
                        </tr>
                               <tr>
                        <td class="sideTitle"><div style="border-bottom: #FF7E3E solid 1px;">
                          <h3 style="padding: 0; margin: 0; font-family: Arial, Helvetica, sans-serif; font-size: 14px; font-weight: bold; color: #F68025;"><br>
Faculty</h3>
                        </div>
                        </td></tr>
                        <tr>
                          <td valign="top"><p style="font-family: Arial; font-size: 12px; font-weight: normal; color: #4c4c4c;">
                            Fr&eacute;d&eacute;ric Amant, MD, PhD <br>
Catholic University <br>
Leuven, Belgium <br>
 <br>
Michael Birrer, MD, PhD <br>
Massachusetts General Hospital <br>
Boston, Massachusetts, United States <br>
 <br>
Anna Fagotti, MD, PhD <br>
Catholic University of the Sacred Heart <br>
Rome, Italy <br>
 <br>
Phillip Harter, MD <br>
Klinikum Essen Mitte <br>
Essen, Germany <br>
 <br>
Felix Hilpert, MD, DMSci <br>
Christian-Albrechts-University of Kiel <br>
Kiel, Germany <br>
 <br>
Sven Mahner, MD, PhD <br>
University Medical Center Hamburg-Eppendorf <br>
Hamburg, Germany <br>
 <br>
Mansoor Mirza, MD <br>
Rigshospitalet <br>
Copenhagen, Denmark <br>
 <br>
Philippe Morice, MD <br>
Institute Gustave Roussy <br>
Villejuif, France <br>
 <br>
Jan Persson, MD, PhD <br>
Lund University <br>
Lund, Sweden <br>
 <br>
Jaime Prat, MD, PhD, FRCPath <br>
Hospital de la Santa Creu i Sant Pau <br>
Barcelona, Spain <br>
 <br>
Vincent Vandecaveye, MD, PhD <br>
University of Leuven <br>
Leuven, Belgium <br>
                        
</p></td>
                        </tr>
                        <tr>
                        <td class="sideTitle"><div style="border-bottom: #FF7E3E solid 1px;">
                          <h3 style="padding: 0; margin: 0; font-family: Arial, Helvetica, sans-serif; font-size: 14px; font-weight: bold; color: #F68025;"><br>
Provider </h3>
                        </div>
                        </td></tr>
                        <tr>
                        <td valign="top"><p style="font-family: Arial; font-size: 12px; font-weight: normal; color: #4c4c4c;">

This is a prIME Oncology activity.<br>

</p>
</td>
                        </tr><tr>
                          <td valign="top" align="center">
<img src="http://www.primeoncology.org/live_education/solid_tumor/~/media/Images/Sponsor/prime.ashx" alt="prIME Oncology"></td>
                        </tr><tr>
                        <td class="sideTitle"><div style="border-bottom: #FF7E3E solid 1px;">
                          <h3 style="padding: 0; margin: 0; font-family: Arial, Helvetica, sans-serif; font-size: 14px; font-weight: bold; color: #F68025;"><br>
Support  </h3>
                        </div>
                        </td></tr>
                        <tr>
                          <td valign="top"><p style="font-family: Arial; font-size: 12px; font-weight: normal; color: #4c4c4c;">This educational activity is industry supported.<br>

</p></td>
                        </tr>
                        
                        
                        <tr>
                        <td class="sideTitle"><div style="border-bottom: #FF7E3E solid 1px;">
                          <h3 style="padding: 0; margin: 0; font-family: Arial, Helvetica, sans-serif; font-size: 14px; font-weight: bold; color: #F68025;"><br>
Continuing Education</h3>
                        </div>
                        </td></tr>
                        <tr>
                        <tr>
                        <td>
<p style="font-family: Arial; font-size: 12px; font-weight: normal; color: #4c4c4c;">An application has been made to the EACCME<sup>&reg;</sup> for CME Accreditation of this event.</p></td>
                        </tr>
                        
                        
                        
                        

                    </table>
                    </td>
                </tr>
 

 
    
<tr>
                <td colspan="3" align="center">
                 <table cellspacing="0" cellpadding="4" width="100%">
                      <tr>
                      
                      
                      
                      
                      
                      </tr>
                    </table>  
                
                </td>


                </tr>                
                
                            <tr>
                <td colspan="3" align="center">
                <br>
                <br>

                    <a href="http://www.primeoncology.org/live_education/solid_tumor/gyncongress2015.aspx" style="text-decoration: none;"><img src="http://primehc.org/email/ascoBC/register.gif" border="0" alt="Register Now" style="border: none;" /></a>
                <br>
                        <p style="padding: 0; margin: 4px 0 0 0; font-family: Arial; font-size: 12px; font-weight: normal; color: #4c4c4c;">Please go to our Website for full registration fee information.</p>
<br>

                </td>
                </tr>
              </table></td>
            </tr>
            <tr>
              <td class="footer" align="left" style="padding: 5px;">
              


               </td>
            </tr>
            <tr>

              <td class="footer" align="center" style="padding: 20px 0; background-color:#666">
               <p style="font-size: 14px;color: #fff;margin: 0;padding: 0;font-family: Arial;"><strong>Follow us</strong></p>
              <table border="0" cellspacing="20">
  <tr>
    <td><a href="https://plus.google.com/109069474896753641435" rel="publisher"><img src="http://www.primeoncology.org/~/media/Images/Image%20Links/google.ashx"></a></td>
    <td><a href="https://twitter.com/prIME_Oncology"><img src="http://www.primeoncology.org/~/media/Images/Image%20Links/twitter.ashx"></a></td>
    <td><a href="http://www.youtube.com/user/prIMEOncologyUpdate"><img src="http://www.primeoncology.org/~/media/Images/Image%20Links/youtube.ashx"></a></td>
    <td><a href="http://www.facebook.com/pages/Prime-Oncology/364934120249753"><img src="http://www.primeoncology.org/~/media/Images/Image%20Links/facebook.ashx"></a></td>
    <td><a href="http://www.linkedin.com/company/prime-oncology/"><img src="http://www.primeoncology.org/~/media/Images/Image%20Links/linkedin.ashx"></a></td>
  </tr>
</table>
              
              
              <p style="padding: 0; margin: 0; font-family: Arial; font-size: 11px; font-weight: normal; color: #4c4c4c;">&nbsp;</p>
                <p style="font-size: 11px;color: #bbb;margin: 0;padding: 0;font-family: Arial;"><strong>prIME Oncology  &nbsp;&nbsp; </strong>
                Schenkkade 50, 2595 AR The Hague, the Netherlands</p>
               </td>
            </tr>
          </table></td>
        </tr>
     </table></td>
   </tr>
</table>


</body>
</html>
​